ATP2B1, ATPase plasma membrane Ca2+ transporting 1, 490
N. diseases: 57; N. variants: 23
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
group | Cardiovascular Diseases | Disease or Syndrome | 2322 | 1085 | 0.700 | None | 0.966 | 29 | 11 | 1999 | 2019 | ||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 1708 | 1577 | 0.430 | None | 1.000 | 7 | 5 | 2012 | 2019 | ||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 1282 | 440 | 0.310 | None | 1.000 | 2 | 2012 | 2019 | |||||
|
disease | Eye Diseases | Acquired Abnormality | 878 | 124 | 0.300 | None | 1.000 | 1 | 2004 | 2004 | |||||
|
phenotype | Eye Diseases | Finding | 24 | 0.300 | None | 1.000 | 1 | 2004 | 2004 | ||||||
|
disease | Eye Diseases | Disease or Syndrome | 28 | 0.300 | None | 1.000 | 1 | 2004 | 2004 | ||||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 1576 | 1178 | 0.110 | None | 1.000 | 4 | 4 | 2011 | 2019 | ||||
|
disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Disease or Syndrome | 1800 | 680 | 0.110 | None | 1.000 | 2 | 1 | 2013 | 2015 | ||||
|
group | Neoplasms | Neoplastic Process | 8621 | 1641 | 0.110 | None | 1.000 | 2 | 1 | 2016 | 2018 | ||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 17 | 12 | 2009 | 2019 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 13 | 11 | 2009 | 2018 | |||||
|
phenotype | Finding | 146 | 344 | 0.100 | None | 1.000 | 8 | 10 | 2011 | 2018 | |||||
|
phenotype | Organism Function | 109 | 220 | 0.100 | None | 1.000 | 4 | 4 | 2011 | 2013 | |||||
|
phenotype | Diagnostic Procedure | 54 | 95 | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2018 | |||||
|
phenotype | Diagnostic Procedure | 35 | 81 | 0.100 | None | 1.000 | 2 | 2 | 2009 | 2018 | |||||
|
phenotype | Finding | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Organism Attribute | 565 | 1138 | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||
|
group | Nervous System Diseases; Cardiovascular Diseases | Disease or Syndrome | 1658 | 591 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||
|
phenotype | Laboratory Procedure | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 23 | 71 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Laboratory Procedure | 563 | 1418 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 545 | 1440 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Clinical Attribute | 1014 | 2689 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Disease or Syndrome | 939 | 584 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 1756 | 711 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |